Disclosure Of First-Time Adoption [Text Block]

ERYTECH Pharma S.A. - Filing #880081

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
25 293 EUR
22 845 EUR
53 797 EUR
97 618 EUR
1 215 EUR
3 102 EUR
2 006 EUR
1 744 EUR
24 616 EUR
120 705 EUR
26 539 EUR
73 300 EUR
136 607 EUR
1 344 EUR
281 688 EUR
85 560 EUR
1 794 EUR
62 659 EUR
99 524 EUR
188,000 EUR
281 744 EUR
145 602 EUR
1 794 EUR
38 224 EUR
Comprehensive income
68,000 EUR
EUR
528,000 EUR
53 797 EUR
EUR
54 257 EUR
72 919 EUR
19,000 EUR
EUR
400,000 EUR
EUR
73 300 EUR
38,000 EUR
1 237 EUR
61 460 EUR
EUR
62 659 EUR
EUR
Profit (loss)
53 797 EUR
53 797 EUR
73 300 EUR
73 300 EUR
62 659 EUR
62 659 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.